U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07436338) titled 'ABO- or HLA- Incompatible LDKT Compared to Waitlist/DDKT in Elderly Patients' on Feb. 21.
Brief Summary: This retrospective multicenter cohort study evaluates the survival outcomes of elderly patients (aged >=60 years) with end-stage kidney disease who underwent ABO- or HLA-incompatible living donor kidney transplantation compared with those managed with a conventional waitlisting strategy, including deceased donor kidney transplantation or remaining on the waiting list.
Elderly patients often experience prolonged waiting times for deceased donor transplantation, during which dialysis-related complications may increase the risk of ...